Literature DB >> 33619302

Severe hypoglycemia and the risk of end stage renal disease in type 2 diabetes.

Jae-Seung Yun1, Yong-Moon Park2, Kyungdo Han3, Hyung-Wook Kim4, Seon-Ah Cha1, Yu-Bae Ahn1, Seung-Hyun Ko5.   

Abstract

We investigated the association between the incidence of severe hypoglycemia and the risk of end-stage renal disease (ESRD) in patients with type 2 diabetes. Baseline and follow-up data for 988,333 participants with type 2 diabetes were retrieved from the National Health Insurance System database. The number of severe hypoglycemia episodes experienced from 2007 to 2009 was determined. The primary outcome was the development of ESRD after the baseline evaluation. Participants were followed from the baseline until death or December 31, 2016, during this period 14,545 participants (1.5%) developed ESRD. In the crude model, compared with those who experienced no severe hypoglycemia, the hazard ratios (95% confidential intervals) for developing ESRD were 4.96 (4.57-5.39), 6.84 (5.62-8.32), and 9.51 (7.14-12.66) in participants who experienced one, two, and three or more episodes of severe hypoglycemia, respectively. Further adjustment for various confounding factors attenuated the association between severe hypoglycemia and ESRD; the significance of the association between severe hypoglycemia and ESRD was maintained. Having three or more severe hypoglycemia episodes was associated with a nearly two-fold increased risk of developing ESRD. Prior episodes of severe hypoglycemia were associated with an increased risk of ESRD among Korean adults with type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33619302      PMCID: PMC7900096          DOI: 10.1038/s41598-021-82838-5

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  32 in total

1.  Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial.

Authors:  Faramarz Ismail-Beigi; Timothy Craven; Mary Ann Banerji; Jan Basile; Jorge Calles; Robert M Cohen; Robert Cuddihy; William C Cushman; Saul Genuth; Richard H Grimm; Bruce P Hamilton; Byron Hoogwerf; Diane Karl; Lois Katz; Armand Krikorian; Patrick O'Connor; Rodica Pop-Busui; Ulrich Schubart; Debra Simmons; Harris Taylor; Abraham Thomas; Daniel Weiss; Irene Hramiak
Journal:  Lancet       Date:  2010-06-30       Impact factor: 79.321

Review 2.  6. Glycemic Targets: Standards of Medical Care in Diabetes-2019.

Authors: 
Journal:  Diabetes Care       Date:  2019-01       Impact factor: 19.112

3.  The impact of severe hypoglycemia on renal impairment in type 2 diabetes.

Authors:  Yu-Li Lee; Brian K Chen; Kun-Der Lin; Rong-Wei Su; Mei-Yueh Lee; Pi-Jung Hsiao; Shyi-Jang Shin
Journal:  Diabetes Res Clin Pract       Date:  2015-03-03       Impact factor: 5.602

Review 4.  Markers of and risk factors for the development and progression of diabetic kidney disease.

Authors:  Richard J Macisaac; Elif I Ekinci; George Jerums
Journal:  Am J Kidney Dis       Date:  2014-02       Impact factor: 8.860

5.  Inflammation and Progression of CKD: The CRIC Study.

Authors:  Richard L Amdur; Harold I Feldman; Jayanta Gupta; Wei Yang; Peter Kanetsky; Michael Shlipak; Mahboob Rahman; James P Lash; Raymond R Townsend; Akinlolu Ojo; Akshay Roy-Chaudhury; Alan S Go; Marshall Joffe; Jiang He; Vaidyanathapuram S Balakrishnan; Paul L Kimmel; John W Kusek; Dominic S Raj
Journal:  Clin J Am Soc Nephrol       Date:  2016-06-23       Impact factor: 8.237

6.  Impact of hypoglycemia associated with antihyperglycemic medications on vascular risks in veterans with type 2 diabetes.

Authors:  Yingnan Zhao; Claudia R Campbell; Vivian Fonseca; Lizheng Shi
Journal:  Diabetes Care       Date:  2012-03-19       Impact factor: 19.112

Review 7.  Risk Factors and Adverse Outcomes of Severe Hypoglycemia in Type 2 Diabetes Mellitus.

Authors:  Jae Seung Yun; Seung Hyun Ko
Journal:  Diabetes Metab J       Date:  2016-10-05       Impact factor: 5.376

Review 8.  Past and Current Status of Adult Type 2 Diabetes Mellitus Management in Korea: A National Health Insurance Service Database Analysis.

Authors:  Seung Hyun Ko; Kyungdo Han; Yong Ho Lee; Junghyun Noh; Cheol Young Park; Dae Jung Kim; Chang Hee Jung; Ki Up Lee; Kyung Soo Ko
Journal:  Diabetes Metab J       Date:  2018-04       Impact factor: 5.376

9.  Severe Hypoglycemia as a Predictor of End-Stage Renal Disease in Type 2 Diabetes: A National Cohort Study.

Authors:  Yu-Li Lee; Shih-Jung Yen; Shyi-Jang Shin; Yi-Chi Huang; Jiun Shiuan He; Kun-Der Lin
Journal:  Int J Environ Res Public Health       Date:  2019-02-26       Impact factor: 3.390

Review 10.  Diabetic kidney disease: from epidemiology to clinical perspectives.

Authors:  Cheol Whee Park
Journal:  Diabetes Metab J       Date:  2014-08       Impact factor: 5.376

View more
  2 in total

1.  Hypoglycemia, Vascular Disease and Cognitive Dysfunction in Diabetes: Insights from Text Mining-Based Reconstruction and Bioinformatics Analysis of the Gene Networks.

Authors:  Olga V Saik; Vadim V Klimontov
Journal:  Int J Mol Sci       Date:  2021-11-17       Impact factor: 5.923

2.  Reproductive Life Span and Severe Hypoglycemia Risk in Postmenopausal Women with Type 2 Diabetes Mellitus.

Authors:  Soyeon Kang; Yong-Moon Park; Dong Jin Kwon; Youn-Jee Chung; Jeong Namkung; Kyungdo Han; Seung-Hyun Ko
Journal:  Diabetes Metab J       Date:  2022-01-24       Impact factor: 5.893

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.